drugset / Trial / NCT00540956
Natural Killer Cells in Older Patients With Acute Myeloid Leukemia
Open-labelTreatment
Summary
RATIONALE: Studying natural killer cells in samples of blood from patients with cancer may help doctors find out how these cells are effected by chemotherapy. PURPOSE: This clinical trial is studying natural killer cells in older patients with acute myeloid leukemia.
Timeline
- Start
- 2006-11
- Primary completion
- 2011-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cytarabine | Small molecule | — | — |